19-38496283-C-T

Variant summary

Our verdict is Uncertain significance.
+5 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 5 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_ModerateO3_SupportingO6_SupportingO7_Supporting

The NM_000540.3(RYR1):c.6617C>T (p.Thr2206Met) variant causes a missense change involving the alteration of a conserved nucleotide. The gene RYR1 is a tumor suppressor gene (CancerMine: 1 TSG, 1 oncogene citations). The gene RYR1 is a known oncogene (CancerMine: 1 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.0000223 (AC=36) in the gnomAD database across 1,613,882 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000197. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.91). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV001434860: Multiple independent in vitro experiments showed this variant is functionally damaging (PMID 12220451, 19648156, 27586648)." and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.T2206R: not_provided (ClinVar VariationId 133164); p.T2206= (synonymous): Likely_benign (ClinVar VariationId 2144678, 2 stars) This exact variant is curated in the UniProt human variants database as Pathogenic, associated with Malignant hyperthermia, susceptibility to, 1 (mhs1).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

RYR1
NM_000540.3 missense

Scores

15
3

Clinical Significance

Pathogenic reviewed by expert panel P:28O:2

Conservation

PhyloP100: 7.91

Publications

5 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • RYR1-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • central core myopathy
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000540.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 5 points.

O1Established oncogenic variant
TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★★)
O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000020 — very rare (O3 supporting [+1])
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 5 pathogenic, 0 benign (OR vs. background: 55.0); Variant does not impact splicing — splice-hotspot path not applicable

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

RYR1 NM_000540.3
MANE Select
HGVSc / HGVSpc.6617C>Tp.Thr2206Met
Exon rankExon 40 of 106
missense
Prot: NP_000531.2UniProt: P21817-1
RYR1 NM_001042723.2
HGVSc / HGVSpc.6617C>Tp.Thr2206Met
Exon rankExon 40 of 105
missense
Prot: NP_001036188.1UniProt: P21817-2

Ensembl Transcripts

RYR1 ENST00000359596.8
TSL:5MANE Select
HGVSc / HGVSpc.6617C>Tp.Thr2206Met
Exon rankExon 40 of 106
missense
Prot: ENSP00000352608.2UniProt: P21817-1
RYR1 ENST00000355481.8
TSL:1
HGVSc / HGVSpc.6617C>Tp.Thr2206Met
Exon rankExon 40 of 105
missense
Prot: ENSP00000347667.3UniProt: P21817-2
RYR1 ENST00000594335.6
TSL:1
HGVSc / HGVSpn.6617C>T
Exon rankExon 40 of 103
non_coding_transcript_exon
Prot: ENSP00000470927.2UniProt: M0R014

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0000394
AC:6
Hom:0
AN:152168
Cov:32
GnomAD2 exomes
AF: 0.0000199
AC:5
AN:251224
GnomAD4 exome
AF: 0.0000205
AC:30
Hom:0
AN:1461714
Cov:32
GnomAD4 genome
AF: 0.0000394
AC:6
Hom:0
AN:152168
Cov:32
TOPMed (Bravo)
AF: 0.0000302
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000464
AC:4
Hom:0
AN:86150
Local & regional cohorts 2 sources
ChinaMAP Phase 1
AF: 0.0000492
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.00000800
AC:1
Hom:0
AN:122320
Showing 8 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.000104 *19620 0.00 *010426
BipEx
(Bipolar disorder (including schizoaffective))
0.0000352 128420 0.0000347 128844
Epi25
(Epilepsy)
0.00 041956 0.0000299 266886
SCHEMA
(Schizophrenia)
0.0000412 497204 0.0000191 3156662
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
13
-
-
Malignant hyperthermia, susceptibility to, 1 (14)
6
-
-
not provided (7)
2
-
-
Malignant hyperthermia of anesthesia (2)
1
-
-
Inborn genetic diseases (1)
1
-
-
King Denborough syndrome (1)
1
-
-
King Denborough syndrome;C1850674:Congenital multicore myopathy with external ophthalmoplegia;C2930980:Malignant hyperthermia, susceptibility to, 1;C5830701:Central core myopathy (1)
1
-
-
King Denborough syndrome;C5830701:Central core myopathy (1)
1
-
-
Malignant hyperthermia, susceptibility to (1)
1
-
-
Ptosis;C0344490:Absence of the sacrum;na:History of neonatal hypotonia (1)
1
-
-
RYR1-related disorder (1)

Computational Scores

AlphaGenome AVI
Pathogenic26
AlphaMissense
Pathogenic0.75
BayesDel_addAF
Pathogenic0.46D
BayesDel_noAF
Pathogenic0.49
CADD
Uncertain25
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.94D
Eigen
Pathogenic0.71
Eigen_PC
Uncertain0.66
FATHMM_MKL
Pathogenic0.98D
GPN-Star LLR
N/A-8.6
GPN-Star score
N/A8.6
LIST_S2
Pathogenic1.0D
M_CAP
Pathogenic0.66D
MetaRNN
Pathogenic0.95D
MetaSVM
Pathogenic1.0D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Uncertain2.5M
PhyloP100
Pathogenic7.9
PrimateAI
Pathogenic0.90D
PROVEAN
Pathogenic-5.2D
REVEL
Pathogenic0.95
Sift
Pathogenic0.0D
Varity_R
N/A0.72
VESM-3B
Benign-9.4
Showing 25 of 25 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.